TVTX position history
The shares of Travere Therapeutics (TVTX) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 34,315 shares, $1.9M, 0.02% of portfolio, New
- 2026 Q3: 52,988 shares, $3.1M, 0.03% of portfolio, Add +54.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|